Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2025 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2025 Earnings Call Transcript November 3, 2025Hims & Hers Health, Inc. reports earnings inline with expectations.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Proem Advisors Imran Khan | 85,000 | $4,821,200 | -82% | 0.51% |
| 2. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | $4,751.50 | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.10 | 2,637 | $132,113.70 | 158,493 | 2025-10-27 | Filing | |
| $57.13 | 11,592 | $662,221.98 | 70,232 | 2025-10-17 | Filing | |
| $62.70 | 16,667 | $1,044,969.23 | 92,523 | 2025-10-16 | Filing | |
| $63.39 | 2,335 | $148,009.35 | 109,190 | 2025-10-16 | Filing | |
| $62.70 | 39,332 | $2,466,112.47 | 111,525 | 2025-10-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,873,300 | $106,253,576 | 0.04% | |
| 2. | Imc-chicago, LlcCALL | 1,532,800 | $86,940,416 | 0.03% |
| 3. | 1,339,702 | $75,987,916 | 0.01% | |
| 4. | 701,845 | $39,808,648 | 5.71% | |
| 5. | 673,213 | $38,184,642 | 0.02% |
News See All
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Business Ontology’s Substack by Lorenzo Bastianelli. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers (HIMS) Soars 16% as Firm On Track to Book $1 Billion Revenues from Women Segment
Hims & Hers soared by 16.18 percent on Wednesday to end at $62.76 apiece as investors cheered the company’s optimism that it would surpass its $1 billion revenue target from women’s health alone in...
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives
In a social media post over the weekend, Hims & Hers Health Inc.
16 Stocks Jim Cramer Recently Talked About
“I want you to keep in mind that September is a pivotal month for the sportsbooks because it marks the start of the football season. It's make or break for these companies….
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on PatchTogether Investing’s Substack. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms
Hims & Hers snapped a two-day losing streak on Wednesday, adding 7.06 percent to finish at $44.46 apiece as investors turned optimistic for telehealth companies after a US judge tossed Eli Lilly’s lawsuit...
Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best Russell 2000 stocks to buy now.
12 Best Russell 2000 Stocks to Buy Now
In its Weekly Market Monitor report for the week ending August 8, 2025, Goldman Sachs noted that U.S. equities had firmly recovered from their April lows.
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares
In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while Chief Medical Officer Patrick Carroll disposed of 60,000 shares for a total of...
Hedge Fund Resource Center Billionaire Hedge Funds
